Stay updated on Pembrolizumab vs. Liver-Directed Therapy in NET Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab vs. Liver-Directed Therapy in NET Clinical Trial page.

Latest updates to the Pembrolizumab vs. Liver-Directed Therapy in NET Clinical Trial page
- ChecktodayChange DetectedPage revision updated from v3.5.3 to v3.5.4, signaling a newer version of the study record page. This appears to be a metadata update rather than a substantive change to the trial details or eligibility criteria.SummaryDifference0.1%

- Check7 days agoNo Change Detected
- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedThe page revision identifier was incremented from v3.5.2 to v3.5.3, reflecting a site/version update rather than a change to the trial study details.SummaryDifference0.1%

- Check29 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check57 days agoChange DetectedRevision: v3.5.0 was rolled out, replacing the previous v3.4.3 release. The update appears to be a routine site version upgrade with no visible changes to the study details or functionality on this page.SummaryDifference0.1%

- Check65 days agoChange DetectedVersion bumped from v3.4.2 to v3.4.3 on the site.SummaryDifference0.1%

- Check93 days agoChange DetectedRevision: v3.4.2 replaces v3.4.1 in the page metadata. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab vs. Liver-Directed Therapy in NET Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab vs. Liver-Directed Therapy in NET Clinical Trial page.